ethambutol has been researched along with Disease Exacerbation in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, F; Sriaroon, C; Walter, J; Zeitler, K | 1 |
| Marks, SM; Mase, SR; Morris, SB | 1 |
| Carrera-Pineda, R; Garcia-Luna, RC; Soto-Cabrera, E; Villamil-Osorio, LV | 1 |
| Boerrigter, BG; van den Berk, GE; van Sandwijk, MS | 1 |
| Jeong, BH; Jeong, YJ; Kim, HJ; Koh, WJ; Lee, G; Lee, KS; Moon, JW; Woo, S | 1 |
| Amoroso, A; Britt, EJ; Burke, AP; Franco, M; Reed, RM | 1 |
| Dhanlaklshmi, M; Ethirajan, N; Padmavathy, L; Rao, LL | 1 |
| Inge, LD; Wilson, JW | 1 |
| Horcajada, JP; Pelfort, X; Puig, L; Salvadó, M | 1 |
| Randhawa, K; Smethurst, P; Soo Hoo, GW | 1 |
| Castro, A; Frisch, IB; Krastel, H; Kunze, AK; Meinck, HM | 1 |
| Chang, MY; Chen, YC; Fang, JT | 1 |
| Chacko, AG; Chandy, MJ; Moorthy, RK | 1 |
| Ali, S; Usman, U; Wasay, M | 1 |
| Ader, F; Bernard, L; Carlier, R; Perronne, C; Salomon, J; Toubiana, J | 1 |
| Asakuma, J; Asano, T; Hayakawa, M; Kawamoto, H; Kobayashi, H; Tanimoto, T | 1 |
2 review(s) available for ethambutol and Disease Exacerbation
| Article | Year |
|---|---|
Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Disease Progression; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; Latent Tuberculosis; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2017 |
Ethambutol-induced optic neuritis in patients with end stage renal disease on hemodialysis: two case reports and literature review.
Topics: Adult; Blindness; Disease Progression; Ethambutol; Female; Humans; Kidney Failure, Chronic; Middle Aged; Optic Neuritis; Renal Dialysis; Risk Assessment; Severity of Illness Index; Tuberculosis, Pulmonary; Vision, Low; Visual Acuity | 2004 |
14 other study(ies) available for ethambutol and Disease Exacerbation
| Article | Year |
|---|---|
Recurrent disseminated
Topics: Adult; Anti-Bacterial Agents; Asian People; Autoantibodies; Azithromycin; Bacteremia; Disease Progression; Ethambutol; Female; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon-gamma; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pericarditis; Pleurisy; Pneumonia, Bacterial; Recurrence; Rifampin; Rituximab; Thailand | 2021 |
[Optochiasmatic tuberculomas as a paradoxical reaction to treatment for meningeal tuberculosis].
Topics: Adult; Antitubercular Agents; Brain Infarction; Diagnostic Errors; Disease Progression; Drug Resistance, Microbial; Drug Substitution; Ethambutol; Female; Host-Pathogen Interactions; Humans; Isoniazid; Magnetic Resonance Imaging; Meningitis, Viral; Moxifloxacin; Mycobacterium tuberculosis; Neuroimaging; Optic Chiasm; Paresis; Prednisone; Pyrazinamide; Rifampin; Thalamus; Tuberculoma; Tuberculosis, Meningeal; Vision Disorders | 2018 |
A breathtaking response to tuberculosis therapy.
Topics: Adult; Antitubercular Agents; Disease Progression; Dyspnea; Ethambutol; Female; Humans; Isoniazid; Mediastinum; Pericarditis, Tuberculous; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Lymph Node | 2013 |
Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Middle Aged; Multiple Pulmonary Nodules; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Proportional Hazards Models; Retrospective Studies; Rifampin; Tomography, X-Ray Computed | 2013 |
Pulmonary mycobacterial spindle cell pseudotumor in a lung transplant patient: progression without therapy and response to therapy.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Disease Progression; Ethambutol; Female; Fluoroquinolones; Humans; Immunocompromised Host; Lung; Lung Transplantation; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Treatment Outcome | 2015 |
Psoriasiform lupus vulgaris.
Topics: Adolescent; Antitubercular Agents; Biopsy; Buttocks; Child; Disease Progression; Ethambutol; Female; Humans; Isoniazid; Lupus Vulgaris; Pyrazinamide; Pyridoxine; Rifampin; Tuberculin Test; Vitamin B Complex | 2008 |
Update on the treatment of tuberculosis.
Topics: Antitubercular Agents; Comorbidity; Directly Observed Therapy; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Mass Screening; Mycobacterium tuberculosis; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Risk Factors; Tuberculin Test; Tuberculosis | 2008 |
[Pain, swelling, and progressive weakness of the left knee over 6 years].
Topics: Accidents, Traffic; Antitubercular Agents; Arthritis, Infectious; Disease Progression; Ethambutol; Humans; Isoniazid; Knee Injuries; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin | 2008 |
Nine-year progression of untreated pulmonary Mycobacterium szulgai infection.
Topics: Antitubercular Agents; Clarithromycin; Delayed Diagnosis; Disease Progression; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2010 |
[Severe course and contingent risk factors in optic neuropathy and myelopathy after tuberculostatics].
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Optic Nerve Diseases; Photophobia; Pyrazinamide; Rifampin; Risk Factors; Risk Management; Spinal Cord Diseases; Treatment Outcome; Tuberculosis, Lymph Node | 2003 |
The transpedicular approach in the management of thoracic spine tuberculosis: a short-term follow up study.
Topics: Abscess; Adolescent; Adult; Aged; Antitubercular Agents; Braces; Combined Modality Therapy; Curettage; Debridement; Decompression, Surgical; Disease Progression; Drainage; Ethambutol; Female; Follow-Up Studies; Humans; Immobilization; Isoniazid; Kyphosis; Male; Middle Aged; Movement Disorders; Pyrazinamide; Radiography; Recovery of Function; Retrospective Studies; Rifampin; Severity of Illness Index; Spinal Cord Compression; Thoracic Vertebrae; Treatment Outcome; Tuberculosis, Spinal | 2004 |
Rapidly developing optic neuritis secondary to ethambutol: possible mechanism of injury.
Topics: Adult; Antitubercular Agents; Disease Progression; Ethambutol; Female; Humans; Optic Neuritis; Time Factors | 2005 |
[Cervical spondylodiscitis: one pathogen may hide another].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Cervical Vertebrae; Cholecystitis; Discitis; Disease Progression; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Ethambutol; Fluoroquinolones; France; Humans; Immobilization; Isoniazid; Male; Middle Aged; Morocco; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Radiography; Rifampin; Tuberculosis, Spinal | 2006 |
Paradoxical worsening of tuberculosis after anti-TB therapy in a kidney transplant recipient.
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunosuppressive Agents; Isoniazid; Kidney Transplantation; Living Donors; Mycobacterium tuberculosis; Postoperative Complications; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2000 |